• HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

  • Apr 19 2025
  • Length: 1 hr and 40 mins
  • Podcast

HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

  • Summary

  • Featuring perspectives from Dr Aditya Bardia, Dr Virginia F Borges, Dr Harold J Burstein and Dr Joyce O’Shaughnessy, including the following topics:

    • Introduction (0:00)
    • HER2-Positive Breast Cancer — Dr O’Shaughnessy (3:13)
    • Triple-Negative Breast Cancer — Dr Bardia (32:56)
    • Personalizing Adjuvant Therapy for Patients with HR-Positive Breast Cancer — Dr Borges (57:35)
    • Current Role of CDK4/6 Inhibitors in the Localized Setting — Dr Burstein (1:25:15)

    CME information and select publications

    Show more Show less
adbl_web_global_use_to_activate_webcro768_stickypopup

What listeners say about HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.